| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1575170A (-)-1-(3, 4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 02/02/2005 | CN1573578A Electrophotographic organophotoreceptors with novel charge transport compounds |
| 02/02/2005 | CN1573577A Organophotoreceptors with azine-based compounds |
| 02/02/2005 | CN1572299A Agents for improving excretory potency of urinary bladder |
| 02/02/2005 | CN1187353C Triazatrinaphthyrins and use thereof |
| 02/02/2005 | CN1187352C Phenanthroline-7-one derivs. and their therapeutic uses |
| 02/02/2005 | CN1187351C Bispidine compounds, their use and preparation method, intermediate and pharmaceutical compositions containing same |
| 02/02/2005 | CN1187350C Bispidine compounds, their use and preparation method, intermediate and pharmaceutical compositions containing same |
| 02/02/2005 | CN1187337C Thiobenzimidazole derivatives |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849642 Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring |
| 02/01/2005 | US6849640 Such as 8-(2,4-dichlorophenyl)-2,3,4,4a,5,9b-hexahydro-1H-pyrido(4,3-b)indole for use as HT3 receptor antagonist, for treatment of depression and obesity |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance |
| 02/01/2005 | US6849620 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 02/01/2005 | US6849619 Substituted pyridoindoles as serotonin agonists and antagonists |
| 02/01/2005 | US6849618 Herbicidal compositions for the desiccation/ defoliation of plants |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 02/01/2005 | US6849367 Photoconductive layer containing azo compound; electrostaticlatent image |
| 02/01/2005 | CA2156078C New imidazopyridines |
| 01/27/2005 | WO2005007672A2 Small molecule toll-like receptor (tlr) antagonists |
| 01/27/2005 | WO2005007658A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007656A1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 01/27/2005 | WO2005007655A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 01/27/2005 | WO2005007654A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |
| 01/27/2005 | WO2005007653A2 Substituted tetrahydro-1h-pyrazolo[3,4-c]pyridines, compositions containing same and use |
| 01/27/2005 | WO2005007652A2 Substituted quinolin-4-ylamine analogues |
| 01/27/2005 | WO2005007634A1 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation |
| 01/27/2005 | WO2005007630A2 Aryl fused azapolycyclic compounds |
| 01/27/2005 | WO2005007099A2 Pkb inhibitors as anti-tumor agents |
| 01/27/2005 | WO2004101512A3 Naphthyridine integrase inhibitors |
| 01/27/2005 | WO2004085418A3 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 01/27/2005 | WO2004064741A3 Compounds, compositions, and methods |
| 01/27/2005 | US20050020830 Heteroaryl fused azapolycyclic compounds |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/27/2005 | US20050020639 Novel compounds |
| 01/27/2005 | US20050020621 Prevent reduced blood flow to brain |
| 01/27/2005 | US20050020620 reaction of gamma -butyrolactones with imidazols; used to make herbicides and oxidative hair dyes |
| 01/27/2005 | US20050020618 Antidiabetic agents; obesity |
| 01/27/2005 | US20050020617 3-substituted oxindole beta3 agonists |
| 01/27/2005 | US20050020616 Central nervous system and psychological disorders |
| 01/27/2005 | US20050020611 Phosphodiesterase inhibitor; antihistamines; antiallergens |
| 01/27/2005 | US20050020605 Quinolyl amide derivatives as CCR-5 antagonists |
| 01/27/2005 | US20050020599 4-(1,3,4,-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof |
| 01/27/2005 | US20050020598 Antiserotonine agents; central nervous system disorders; anxiolytic agents; cognition activators; schizophrenia ; antidepressants; Alzheimer's disease; Parkinson's disease |
| 01/27/2005 | US20050020596 Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands |
| 01/27/2005 | US20050020593 Anticancer agents |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020574 dipeptidylpeptidase-IV inhibitors; treatment of diabetes and obesity |
| 01/27/2005 | US20050020572 Therapy for bacteria infections |
| 01/27/2005 | US20050020568 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 01/27/2005 | US20050019685 Naphthalenetetracarboxylic diimide derivatives and electrophotographic photoconductor containing the same |
| 01/27/2005 | US20050019263 Conjugate for differentiating between healthy and unhealthy tissue |
| 01/27/2005 | CA2573951A1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 01/27/2005 | CA2533100A1 Aryl fused azapolycyclic compounds |
| 01/27/2005 | CA2532122A1 Substituted tetrahydro-1h-pyrazolo[3,4-c]pyridines, compositions containing same and use |
| 01/27/2005 | CA2532013A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |
| 01/27/2005 | CA2531535A1 Substituted quinolin-4-ylamine analogues |
| 01/27/2005 | CA2529193A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 01/27/2005 | CA2528774A1 Small molecule toll-like receptor (tlr) antagonists |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1499624A1 Electroluminescent materials |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499607A1 4-(piperidyl- and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists |
| 01/26/2005 | EP1499598A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 01/26/2005 | EP1499391A2 Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499319A1 Bicyclo 4.4.0 antiviral derivatives |
| 01/26/2005 | EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571671A Drugs comprising combination of triazaspiro [5.5] undecane derivative with cytochrome p450 isozyme 3A4 inhibitor and/or P-glycoprotein inhibitor |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186326C Propane-1, 3-dione derivatives |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/25/2005 | US6846928 Compositions useful as inhibitors of protein kinases |
| 01/25/2005 | US6846840 Alkylating agents possessing both in vitro cytotoxicity and antitumor activity; for therapy of cancer |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846832 Highly selective monoamine oxidase B inhibitors; treating Alzheimer's disease, Parkinson's disease, and senile dementia |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/20/2005 | WO2005005600A2 Camptothecin analogs having an e-ring ketone |
| 01/20/2005 | WO2005005426A1 Isethionate salt of a selective cdk4 inhibitor |
| 01/20/2005 | WO2005005410A1 A method for the preparation of enantiomerically pure mirtazapine |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 01/20/2005 | WO2005004801A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 01/20/2005 | WO2005004607A1 Arylmethyl triazolo and imidazopyrazines as c-met inhibitors |
| 01/20/2005 | WO2004106334A3 Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation |
| 01/20/2005 | WO2004096802A9 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES |
| 01/20/2005 | WO2004092166A3 Cgrp receptor antagonists |